We are live on ! Find out more
MC

Mayo Clinic Portfolio holdings

AUM $2.9M
1-Year Est. Return 14.49%
This Fund
S&P 500
This Quarter Est. Return
+30.64%
1 Year Est. Return
+14.49%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.15M
AUM Growth
-$10M
Cap. Flow
-$10.8M
Cap. Flow %
-175.05%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
1
Closed
3
Avg Time Held
9.6 quarters
Top 10 Avg Time Held
6.6 quarters
Top 20 Avg Time Held
6.6 quarters

Top Buys

Rank Stock Value
1
CATX icon
Perspective Therapeutics
CATX
+$618K

Top Sells

Rank Stock Value
1
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$10.1M
2
IMNM icon
Immunome
IMNM
+$1.16M
3
SCLX icon
Scilex Holding
SCLX
+$86.3K
4
IBRX icon
ImmunityBio
IBRX
+$7.04K

Sector Composition

Rank Sector Weight
1 Healthcare 68.89%
2 Miscellaneous 31.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ZNTL icon
1
Zentalis Pharmaceuticals
ZNTL
$233M
$2.95M 48%
187,143
– –
2020 Q2
15 quarters
ACWI icon
2
iShares MSCI ACWI ETF
ACWI
$33.1B
$1.91M 31.11%
17,359
-96,378
-85% -$10.1M
2022 Q4
5 quarters
CATX icon
3
Perspective Therapeutics
CATX
$266M
$862K 14.03%
+72,464
New +$618K
2024 Q1
0 quarters
NMTC icon
4
NeuroOne Medical Technologies
NMTC
$9.93M
$218K 3.55%
30,292
– –
2021 Q2
11 quarters
UBX icon
5
DELISTED
Unity Biotechnology
UBX
$203K 3.31%
124,081
– –
2019 Q4
17 quarters
IBRX icon
6
ImmunityBio
IBRX
$10.4B
– –
-1,403
Closed -$7.04K –
IMNM icon
7
Immunome
IMNM
$2.09B
– –
-108,480
Closed -$1.16M –
SCLX icon
8
Scilex Holding
SCLX
$20.3M
– –
-1,209
Closed -$86.3K –

Similar funds

Mayo Clinic's Q1 2024 Portfolio in Review

As of Q1 2024, Mayo Clinic held 8 positions worth $6.15M, down 62% from $16.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Mayo Clinic withdrew a net $10.8M in Q1 2024, closing 3 positions and reducing 1 holding. Its most notable exit was Immunome, an estimated $1.16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 29% a quarter earlier, followed by Miscellaneous.

Against the trend, Mayo Clinic opened a new position in Perspective Therapeutics worth $862K.

  • Mayo Clinic's largest Q1 2024 buy was Perspective Therapeutics: 72,464 shares worth $862K.
  • Mayo Clinic's biggest Q1 2024 reduction was iShares MSCI ACWI ETF, cutting an estimated $10.1M.
  • Mayo Clinic fully exited Immunome in Q1 2024, selling an estimated $1.16M.
  • Mayo Clinic's ten largest holdings make up 100% of its $6.15M portfolio in Q1 2024.
  • Mayo Clinic opened 1 new position and closed 3 in Q1 2024.
  • Mayo Clinic's portfolio value fell 62% quarter-over-quarter to $6.15M.

Based on Mayo Clinic's 13F filing for Q1 2024, filed 13 May 2024.